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Die and Let Live: Minireview
Eliminating Dangerous Lymphocytes
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Department of Pathology The central nervous system (CNS), testes, and eyes are
Brigham and Women's Hospital said to be immunologically privileged sites because allo-
and Harvard Medical School geneic or xenogeneic tissues transplanted into these
Boston, Massachusetts 02115 sites are not rejected; that is, these sites are ªprotectedº
from local immune responses. It has been suggested
that any injurious side effects of immunologic reactions
in these tissues would have particularly devastating con-The principal physiologic function of the immune system
sequences for the individual or the species. The mecha-is the elimination of infectious organisms. The effector
nism responsible for immune privilege in the CNS, tes-mechanisms that are responsible for protective immu-
tes, and eye has interested immunologists for manynity are also capable of injuring host tissues. In some
years. Much of the earlier work emphasized anatomicsituations, specific immune responses have little or no
factors, such as the absence of efferent lymphatics fromprotective value, and the harmful consequences be-
the brain and the presence of vascular barriers that maycome dominant; examples include autoimmune dis-
not allow circulating lymphocytes ready access to theseeases caused by pathologic immune responses against
sites. However, it has become increasingly clear thatself-antigens, and infections in which the host response
circulating cells can enter the eyes and testes and thatand not the infectious agent is the main cause of pathol-
antigens introduced in these sites freely enter the circu-ogy. The immune system has evolved multiple, nonover-
lation. How, then, do these tissues maintain their privi-lapping mechanisms for controlling potentially harmful
leged status? The surprising answer is that the testesreactions. Failure of these mechanisms may lead to tis-
and eyes kill any lymphocytes that come too close andsue injury and disease. Conversely, the same regulatory
are activated by antigens, and this killing involves themechanisms may be exploited therapeutically, for in-
Fas±FasL pathway.stance, to prevent the rejection of tissue transplants.
Fas is expressed on a wide variety of cell types, eitherPotentially injurious immune reactions may be pre-
constitutively (as in the liver) or inducibly, after activationvented either by functionally inactivating the responding
(as in lymphocytes). FasL, on the other hand, has anlymphocytes or by killing the cells. The principal cytolytic
extremely restricted tissue distribution. It is rapidly in-mechanism involved in controlling lymphocyte re-
duced on T lymphocytes following their activation bysponses is a tightly regulated pathway of apoptotic cell
antigen, but few cells other than T lymphocytes appeardeath triggered by an interaction of Fas (CD95) with its
to express significant levels of FasL. The earliest de-ligand. Fas is a member of the tumor necrosis factor
scription of the cloning of FasL included data showing(TNF) receptor family of cell surface proteins, and Fas
that transcripts were present in the testis (Suda et al.,ligand (FasL) is a member of the TNF family of membrane
1993). Based on this,Bellgrau et al. (1995) askedwhetherand secreted proteins. The biochemistry of these pro-
FasL expression in the testis was of functional impor-teins and the mechanisms by which Fas triggers
tance. They found that testicular grafts taken from nor-apoptosis have been subjects of recent reviews (Nagata,
mal mice and placed under the kidney capsules of allo-1994; Cleveland and Ihle, 1995). This minireview focuses
geneic recipients were not rejected, but if the testison the physiological functions of the Fas±FasL pathway
grafts were obtained from FasL-mutant gld/gld homozy-and emphasizes the concept that, among all biological
gote mice, they were rejected rapidly.This simple exper-systems, only the immune system has evolved ways of
iment clearly implicated the Fas pathway in the resis-actively eliminating its own potentially harmful cells so
that the host may survive. tance of testis allografts to rejection and suggested the
Figure 1. The Role of Fas±FasL Interaction in
Maintaining Immune Privilege and Self-Tol-
erance
(A) Immune privilege. (B) Immunological self-
tolerance.
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following sequence of reactions to these grafts. Host function of this molecule is the elimination of Fas-ex-
pressing infiltrating leukocytes. On the other hand, wealloreactive T cells enter the graft, recognize alloanti-
gens on testicular tissue, and are activated. As a result, cannot rule out the possibility that the Fas±FasL path-
way also serves some as-yet-unknown nonimmunologicthe T cells begin to express Fas and become targets
for the cytolytic action of FasL, which is normally and function in the testes and eyes.
Immunological Tolerance: Preventing Immuneconstitutively expressed on Sertoli cells in the testis
(Figure 1A). This leads to the unusual situation of the Reactions against Self-Antigens
There are several theoretical and mechanistic parallelsgraft ªrejectingº (killing) host cells and thus protecting
itself. Sertoli cellsmay function as immunological guard- between immune privilege and immunological toler-
ance. In both situations, the underlying mechanism isians to block the development of all immune reactions in
the testis and not just transplant rejection. To establish the inactivation or elimination (or both) of antigen-re-
sponsive lymphocytes. Immune privilege, as discussedformally the role of the Fas±FasL pathway in immune
privilege, it will benecessary toshow that diverse foreign above, is maintained in some tissues because of the
ability of these tissues to destroy infiltrating lympho-protein antigens (including tissue grafts) placed in the
testes of normal mice will not elicit specific immune cytes. Immunological tolerance is maintained in part
by the ability of lymphocytes to kill themselves or oneresponses, whereas the same antigens introduced into
the testes of Fas-deficient lpr/lpr mice or FasL-mutant another. In fact, the situation in which the protective
value of Fas±FasL interactions was first described wasgld/gld mice will stimulate such responses. The testicu-
lar transplant experiments done to date suggest that the prevention of autoimmunity. The seminal observa-
tions that established this idea were the demonstrationthis hypothesis will prove to be correct.
A second study has more directly evaluated the role that in two mouse models of systemic autoimmunity,
lpr and gld homozygous mice, the key abnormalitiesof Fas±FasL interactions in preventing local immune re-
actions, this time in the eye. Griffith et al. (1995) have were defective expression of Fas or a mutation in FasL,
respectively (Nagata and Suda, 1995). Abnormalities inshown that if herpes simplex virus is introduced into the
anterior chamber of the eyes of normal mice, it elicits Fas are also known to cause systemic autoimmune dis-
eases in humans (Rieux-Laucaut et al., 1995; Fisher eta mild, local inflammatory response, with detectable
apoptosis of infiltrating leukocytes. In contrast, the same al., 1995). Such abnormalities include inheritance of two
mutant alleles, undefined signaling defects, and inheri-viral infection in Fas-deficient lpr/lpr mice or FasL-mu-
tant gld/gld mice leads to a more severe inflammation tance of dominant negative mutants. An intriguing ob-
servation is that some children who inherit dominantthat spreads to the posterior chamber. FasL is ex-
pressed on the corneal epithelium, iris, and retina in the negative mutants show defects in Fas-mediated
apoptosis and develop autoimmune disease, whereaseye and presumably functions to kill any leukocytes that
enter in response to the local viral infection and that the parents who carry the mutant genes also show
apoptosis defects but are clinically unaffected (Fisher etexpress Fas. This is supported by the finding that, in
vitro, explants of the cornea and iris from normal eyes, al., 1995). This raises the possibility that the phenotypic
manifestations of disease may be influenced by modi-but not eyes of gld/gld mice, are capable of inducing
apoptosis of Fas-expressing targets. In the case of the fying factors, which have not been identified yet.
The mechanism by which Fas±FasL interactions main-ocular infection, immune privilege is, of course, not ad-
vantageous to the host, because it allows the infection tain immunological tolerance to self-antigens has been
inferred from a variety of studies. It is thought that ifto proceed unchecked.
Fas-dependent leukocyte elimination may not be the CD41 helper T lymphocytes are repeatedly stimulated
by their cognate antigen, these T cells express highonly mechanism for preventing inflammatory immune
responses in the eye. In several experimental studies, levels of Fas and FasL and kill either themselves or one
another (Figure 1B). Such a homeostatic mechanismit has been shown that antigens introduced into the
anterior chamber do elicit immune responses, but such may limit the size of lymphocyte clones responding to
foreign antigens. The same mechanism may be trig-responses tend to be suppressive: that is, they inhibit
potentially injurious, inflammatory immune reactions at gered by abundant and disseminated self-antigens,
which are able to interact repeatedly with specific Tboth local and distant sites (Ksander and Streilein, 1994).
In these situations, immune privilege is not due to a cells. The available evidence indicates that Fas plays
little or no role in selecting developing T cells in thymusfailure of immune responses. Rather, antigens intro-
duced into the eye may induce a form of ªimmune devia- and that abnormalities in Fas are manifested by a defect
in antigen-induced deletion of mature T cells in periph-tionº in which anti-inflammatory immune reactions pre-
dominate. Whether or not FasL-mediated cell death eral lymphoid tissues (Singer and Abbas, 1994). Thus,
in lpr and gld homozygous mice, autoimmunity is associ-plays a role in biasing immune responses toward the
anti-inflammatory route is an open question. ated with a failure of deletion of mature T cells and is
not due to abnormal lymphocyte maturation or selectionTwo other issues relevant to immune privilege are
worth mentioning. First, there is, as yet, no evidence of the repertoire of mature lymphocytes. These findings
also emphasize the importance of peripheral tolerancethat the CNS also constitutively expresses FasL. In fact,
immune privilege in the CNS may be due to anatomic in maintaining unresponsiveness to self-antigens. In ad-
dition to its role in T cell deletion, Fas is also involvedfactors, such as the exclusion of lymphocytes by the
normal blood±brain barrier. Second, it is intriguing that in the elimination of unwanted B lymphocytes. Thus, B
cells that encounter self-antigens may express Fas, maythe eye and the testis are the only tissues that constitu-
tively express FasL. It may be that the only physiologic remain sensitive to killing by FasL expressed on helper
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Prospects for Therapy
These studies on the physiologic functions of Fas and
FasL have raised the exciting possibility that this path-
way can be exploited in a beneficial way. For instance,
it may be feasible to endow allografts or xenografts
with the property of immune privilege, or resistance to
rejection, by expressing FasL in the donor tissues. Obvi-
ously, it will be necessary to show that the tissue in
which FasL is to be expressed does not also express
Fas so that it does not injure itself. Attempts to express
FasL as a transgene in the b cells of the islets of Langer-
hans of mice and to use these FasL1 cells as grafts for
treating diabetes are already underway. In theory, the
same approach may be useful for developing universal
islet xenografts. However, a major barrier to xenotrans-
plantation is antibody-mediated hyperacute rejection,
and this will obviously not be prevented by FasL. In the
long term, one can envision donor tissues expressing
multiple human genes designed to prevent different hu-
moral and cellular mechanisms of graft rejection.
The Fas±FasL pathway may also be exploited for
treating autoimmune diseases. One example of this is
a study in which mice were immunized with a myelin
antigen so that they developed encephalomyelitis. Re-
peated administration of thesame antigen led toelimina-
tion of specific T cells, presumably by Fas-mediated
apoptosis, and to amelioration of disease (Critchfield et
al., 1994). The danger in such a therapeutic protocol is
obvious, since it relies on activating potentially danger-
ous T cells prior to inducing the death of these cells.
Nevertheless, controlled administration of self-antigens
or pharmacologic induction of cell death in autoreactive
lymphocytes may prove to be valuable in the treatment
of autoimmune diseases.
